Cargando…

Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary Study

BACKGROUND: Kidney transplant (KT) recipients are at high risk for developing severe COVID-19. Lowering immunosuppression levels in KT recipients with COVID-19 encourages native immune responses but can raise the risk of rejection. Donor-derived cell-free DNA (dd-cfDNA), reported as a fraction of to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reusing, Jose Otto, Yoo, Jongwon, Desai, Amishi, Brossart, Katya, McCormick, Sarah, Malashevich, Allyson Koyen, Bloom, Michelle S., Fehringer, Gordon, White, Roseann, Billings, Paul R., Tabriziani, Hossein, Demko, Zachary P., Gauthier, Philippe, Akkina, Sanjeev K., David-Neto, Elias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920956/ https://www.ncbi.nlm.nih.gov/pubmed/35618524 http://dx.doi.org/10.1016/j.transproceed.2022.02.027

Ejemplares similares

Clinician‐reported chorionicity and zygosity assignment using single‐nucleotide polymorphism‐based cell‐free DNA: Lessons learned from 55,344 twin pregnancies
por: Wojas, Anna, et al.
Publicado: (2022)

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden
por: Schneider, Charles J., et al.
Publicado: (2021)

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2022)

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
por: Khaddour, Karam, et al.
Publicado: (2022)

Kidney Transplantation for Erdheim-Chester Disease
por: Yoo, Jongwon, et al.
Publicado: (2020)

Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report
por: Azzi, Georges, et al.
Publicado: (2022)

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
por: Cohen, Stacey A., et al.
Publicado: (2022)

Genetic Testing for Chronic Kidney Diseases: Clinical Utility and Barriers Perceived by Nephrologists
por: Mrug, Michal, et al.
Publicado: (2021)

Impact of Maintenance Steroids versus Rapid Steroid Withdrawal in African-American Kidney Transplant Recipients: Comparison of Two Urban Centers
por: Chon, W. James, et al.
Publicado: (2016)

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
por: Bunnapradist, Suphamai, et al.
Publicado: (2021)

BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2021)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
por: Azzi, Georges, et al.
Publicado: (2022)

Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation
por: Tabriziani, Hossein, et al.
Publicado: (2018)

Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
por: Hedriana, Herman, et al.
Publicado: (2019)

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
por: Kim, Paul J., et al.
Publicado: (2022)

Combining the use of a fetal fraction‐based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy
por: Benn, Peter, et al.
Publicado: (2019)

Cardiac risk assessment for end-stage renal disease patients on the renal transplant waiting list
por: Tabriziani, Hossein, et al.
Publicado: (2019)

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
por: Halloran, Philip F., et al.
Publicado: (2023)

Re: Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate
por: Jelsema, R., et al.
Publicado: (2020)

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
por: Rosenheck, J.P., et al.
Publicado: (2022)

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022)

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
por: Loupakis, Fotios, et al.
Publicado: (2021)

Vertebrogenic Pain: A Phenomenon Driving New Understanding of Chronic Axial Low Back Pain
por: McCormick, Zachary L
Publicado: (2022)

Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures
por: DiNonno, Wendy, et al.
Publicado: (2019)

Evaluation of the influence of correcting for gillnet selectivity on the estimation of population parameters
por: Klein, Zachary, et al.
Publicado: (2023)

Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
por: Kasi, Pashtoon M., et al.
Publicado: (2022)

Follow-up of infants with congenital hypothyroidism and low total thyroxine/thyroid stimulating hormone on newborn screen
por: McCormick, Quinn, et al.
Publicado: (2019)

Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
por: Peabody, John, et al.
Publicado: (2019)

A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X
por: Demko, Zachary, et al.
Publicado: (2022)

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation
por: Ventura-Aguiar, Pedro, et al.
Publicado: (2022)

Characterizing the experience of sensitive skin: A pilot survey
por: McCormick, Erika T., et al.
Publicado: (2023)

A Randomized Controlled Trial of a Mobile Medical App for Kidney Transplant Recipients: Effect on Use of Sun Protection
por: Robinson, June K., et al.
Publicado: (2015)

Response Across the Health-Literacy Spectrum of Kidney Transplant Recipients to a Sun-Protection Education Program Delivered on Tablet Computers: Randomized Controlled Trial
por: Robinson, June K, et al.
Publicado: (2015)

Comparative Versus Non-Comparative Dual Lumbar Medial Branch Blocks before Radiofrequency Neurotomy: Is There a Difference in Prognostic Value?
por: Waring, Patrick H, et al.
Publicado: (2021)

Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma
por: Zhou, Maggie, et al.
Publicado: (2022)

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients
por: Altuğ, Yücel, et al.
Publicado: (2019)

Predicting Fibrosis Progression in Renal Transplant Recipients Using Laser-Based Infrared Spectroscopic Imaging
por: Varma, Vishal K., et al.
Publicado: (2018)

Amulets and Cord Blood: Understanding Banking and Regenerative Medicine in Chennai, India
por: Panwar, Amishi
Publicado: (2023)

Thalassemia, biobanking infrastructures, and personalized stem cell therapies in Chennai
por: Panwar, Amishi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ftu9lai2kqvj62h9i784cnr84h